文献速递肝病

淋巴细胞与单核细胞比值作为失代偿期原发性胆汁性胆管炎患者再代偿的预测指标

Lymphocyte-to-Monocyte Ratio as a Predictor of Recompensation in Patients With Decompensated Primary Biliary Cholangitis.
PubMed 文献 · Aliment Pharmacol Ther · 2025-06-23

本研究回顾性分析410例接受熊去氧胆酸治疗的失代偿期原发性胆汁性胆管炎(PBC)相关肝硬化患者,随访期间401例中105例(26.18%)实现再代偿。多因素Cox回归显示较高淋巴细胞与单核细胞比值(LMR)是再代偿的独立促进因素(HR=1.415,95%CI:1.264-1.585,p<0.001),ROC曲线下面积0.787(95%CI:0.736-0.838,p<0.001),预测性能优于其他炎症标志物。

要点

  • 失代偿期PBC相关肝硬化患者中,较高LMR与再代偿独立相关(HR=1.415,95%CI:1.264-1.585,p<0.001)。
  • LMR预测再代偿的AUC为0.787(95%CI:0.736-0.838,p<0.001),优于SII、PLR和NLR。
  • 随访期间401例患者中105例(26.18%)实现再代偿。

核心结论

  • LMR是失代偿期PBC患者再代偿的稳健独立预测指标。

研究设计与样本

  • 回顾性分析410例接受熊去氧胆酸治疗的PBC相关失代偿期肝硬化患者,采用Cox回归分析LMR与再代偿的关联,并按LMR四分位数进行趋势分析,用ROC曲线评估LMR、NLR、SII和PLR的预测准确性,并进行敏感性分析。

主要发现

  • 随访期间401例失代偿期肝硬化患者(年龄60.0岁,IQR:53.0-69.0岁;女性88.3%)中105例(26.18%)实现再代偿。
  • 多因素Cox回归分析显示,调整模型中的所有混杂因素后,较高LMR是再代偿的独立促进因素(HR=1.415,95%CI:1.264-1.585,p<0.001),呈线性正相关趋势。
  • ROC曲线分析显示LMR预测性能优于其他炎症标志物(SII、PLR、NLR),AUC为0.787(95%CI:0.736-0.838,p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary biliary cholangitis (PBC) patients in the decompensated stage face poor prognoses, with recompensation being crucial for improving long-term outcomes. AIM: This study aims to evaluate the predictive value of the lymphocyte-to-monocyte ratio (LMR) for recompensation in decompensated PBC patients. METHODS: We retrospectively analysed 410 patients with PBC-related decompensated cirrhosis receiving ursodeoxycholic acid (UDCA) treatment. The association between the LMR and recompensation was examined using Cox regression analysis, with additional trend analysis performed based on LMR quartiles. The predictive accuracy of the LMR, neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII) and platelet-to-lymphocyte ratio (PLR) was evaluated using receiver operating characteristic (ROC) curve analysis. Sensitivity analyses were conducted to confirm the robustness of the findings. RESULTS: During follow-up, among 401 patients with decompensated cirrhosis (age: 60.0 [IQR: 53.0-69.0] years; 88.3% female), 105 patients (26.18%) achieved recompensation. Multivariate Cox regression analysis showed that higher LMR was an independent promoting factor for recompensation after adjusting for all confounding factors in the model (HR = 1.415, 95% CI: 1.264-1.585, p < 0.001), with a linear positive correlation trend. ROC curve analysis demonstrated that LMR had superior predictive performance compared to other inflammatory markers (SII, PLR, NLR), with an area under the curve (AUC) of 0.787 (95% CI: 0.736-0.838, p < 0.001). CONCLUSION: LMR serves as a robust independent predictor for recompensation in decompensated PBC patients.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Lin H, Zheng M, Huang Y, et al. Lymphocyte-to-Monocyte Ratio as a Predictor of Recompensation in Patients With Decompensated Primary Biliary Cholangitis. Aliment Pharmacol Ther. 2025. PMID: 40546022. doi:10.1111/apt.70233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。